18
10
6
Contents
| JUN/JUL 2015 |
FEATURES
THE ST. LUKE'S EPILEPSY CENTER:
TRANSFORMING CARE FOR INTRACTABLE SEIZURES 6
In the rigorous pursuit of seizure-free outcomes, the Epilepsy Center at St. Luke's
University Health Network marshals leading-edge diagnostic testing, the advanced
capabilities of its Epilepsy Monitoring Unit, and wide-ranging conservative and
surgical interventions.
BLOOD TEST COULD IMPROVE
DIAGNOSIS OF DEPRESSION 10
A newly developed blood test could add a high degree of objectivity to the diagnosis
of depression among adults and create opportunities for psychiatrists to craft more
individualized and effective treatment plans.
LACK OF REGULATION HAMPERS EFFORTS
TO MONITOR STEM CELL TOURISM 14
Minimal transparency regarding untested stem cell treatments performed domestically
and abroad has facilitated the growth of an industry whose outcomes are largely
hidden. Physicians can guide patients toward more promising treatments, however.
BREAST CANCER DRUG THERAPY FINDINGS
ALTER STANDARD OF CARE 16
A three-drug combination that extends survivorship by nearly 16 months among
patients with HER2-positive metastatic breast cancer is considered some of the most
encouraging news in the history of treating the disease.
ON THE COVER:
St. Luke's epileptologists
include Chad Saunders, MD,
Lizbeth de Padua, MD, and
Kuei-Cheng Lim, MD, PhD.
DEPARTMENTS
BUSINESS OF MEDICINE 5
MENTAL HEALTH 12
THAT'S NEWS 13
MATERNAL CARE 18
